Skip to main content
. Author manuscript; available in PMC: 2018 May 30.
Published in final edited form as: Eur J Pharm Sci. 2017 Feb 7;103:60–69. doi: 10.1016/j.ejps.2017.02.005

Table 1.

Number of test compound classified as inhibitors (IC50 < 80 μM), weak inhibitors (IC50 > 80 μM), inactive molecules and stimulators within the five scaffolds in this study. The number in parenthesis respond to the combined number of test compounds from this study and Wissel et al 2015.

Scaffold 1 Scaffold 2 Scaffold 3 Scaffold 4 Scaffold 5 Total
Inhibitor 5 (19) 19(26) 5 (10) 2 (4) 7 (8) 38 (67)
Weak inhib. 6 (10) 8 (17) 1 (4) 7 (11) 18 (18) 40 (60)
Inactive 0 (1) 2 (9) 1 (3) 13 (15) 17 (17) 33 (45)
Stimulator 0 (0) 0 (0) 0 (0) 2 (2) 1 (1) 3 (3)

Total 11(30) 29 (52) 7 (17) 24 (32) 43(44) 114 (175)